A preliminary study of carbamazepine in the treatment of assaultive patients with dementia.
Carbamazepine was administered in an open pilot study to 13 patients with primary degenerative dementia characterized by aggressive and assaultive behavior refractory to conventional treatment. Tentatively, from this preliminary study, carbamazepine appears to have advantages in the treatment of assaultive patients with dementia.